About this event

  • Date and time Thu 4 Jun 2026 from 2:30pm to 6:30pm
  • Location Online
  • Organised by Medicine and Me, Lipoedema UK

Join us for another free, highly-anticipated RSM webinar, delivered in collaboration with Lipoedema UK for the second year in a row, that brings together international medical experts and individuals with lived experience to explore the Lipeodema World Alliance Delphi Consensus-Based Position Paper and receive an update on the NICE review of liposuction guidance for chronic lipoedema. Furthermore, this webinar will consider the future of lipoedema care locally and globally - including improvements in early recognition, differential diagnosis and current treatment approaches.

The consensus paper was developed to establish and support a globally relevant, evidence-based standardised framework for understanding and managing the chronic condition and distinguishing it from obesity and lymphoedema. The paper successfully integrated research evidence with clinical expertise and consensus-based recommendations from several international clinicians, researchers and patient representatives to identify key gaps to improve outcomes for patients living with the condition and to guide consistent approaches for effective management.

Consequently, this webinar provides comprehensive, evidence-based perspectives on the paper, grounded in both global consensus and insights from real-world experience. Additionally, attendees will gain a structured framework for recognising clinical features, diagnosing and navigating this complex condition and applying this knowledge to enhance clinical practice, patient support and identify gaps in care. 

Key areas of discussion

  • Definition and Clinical Presentation: establishing a clear, standardised definition of lipoedema and its distinguishing symptoms as a distinct, clinical condition.
  • Pathophysiology Mechanisms: exploring current understanding of the biological processes of the disease.
  • Epidemiology and Risks: examining prevalence, vulnerable populations and contributing risk factors associated with lipoedema.
  • Co-morbidities and Concomitant Diseases: understanding the range of associated medical conditions, such as obesity and their impact on disease progression, management and patient outcomes.
  • Quality of life and Symptom Burden: assessing the physical, psychological and social impacts of lipoedema, including pain, mobility limitations and overall wellbeing.
  • Diagnostic Frameworks and Approaches: reviewing current diagnostic criteria, clinical approaches to diagnose lipoedema and the key challenges.
  • Treatment Strategies and Management: evaluating conservative, medical and surgical interventions, including their effectiveness and role within care pathways.
  • Future Directions: identifying emerging research, innovations and gaps in lipoedema care to inform future improvements in diagnosis, treatment and patient support.

Who should attend?

  • Consultants or GPs working or interested in:
    • Vascular.
    • Endocrinology.
    • Metabolic disease.
    • Plastic surgery.
    • Dermatology.
    • Lipoedema care. 
    • Patient support.
  • Haematologists.
  • Pharmacists.
  • Women's Health Clinicians.
  • Midwives. 
  • Nurses.
  • Medical researchers.
  • Students interested in lipoedema care.
  • Patients currently living with lipoedema. 
  • Primary Care clinicians.
  • Physiotherapists.
  • Podiatry, lymphoedema and weight management services.

With an emphasis on the importance of early diagnosis and treatment approaches, this 2026 Lipoedema UK webinar ultimately seeks to support more effective advocacy for increased awareness, research, funding and standards of care at both local and national levels.

We would like to thank our anonymous donor for their generous support enabling this platform for patient focused charities and free access to the Medicine and Me series. 

Please note that you may see this condition referred to as both “lipoedema” and “lipedema.” These terms describe the same medical condition. “Lipoedema” is the spelling commonly used in the UK and other countries that follow British English conventions, while “lipedema” is the internationally recognised spelling often used in countries such as the United States. We use “lipoedema” throughout this website, but both terms are interchangeable and refer to the same condition.

Follow us on: 
Facebook 
Instagram
LinkedIn
Twitter 
YouTube 

 

 

 

Key speakers

Professor Manuel Cornely

Scientific Director, LY.SEARCH Germany

Speaker's biography

Professor Manuel E. Cornely is a specialist in dermatology and venereology, and Honorary Professor of the University of Puebla for his services in lymphology. He is also the Founding President of the Professional Association of Lymphologists. He is currently working as a Senior Consultant in Lymphology at the ‘SchönKlinik’ in Düsseldorf, where he is setting up a new department for surgical lymphology.

 

Professor Cornely has been active in lymphological research since 1992. He has been operating regularly and continuously on lipoedema or lymphedema of the arms and legs since 1997. Since 2018, he has been the Scientific Director of the non-profit institute for lymphological basic research LY. SEARCH gGmbH in Düsseldorf. He publishes in national and international journals and is the author and editor of the compendium ‘Applied Lymphology – Fundamentals, Everyday Life, Perspectives.’

 

He developed the procedure Lymphological Liposculpture by Prof. Cornely™ and initiated the paradigm shift on the previously only conservatively treated disease lipoedema through the surgical treatment option. With over 20 years of experience in the diagnosis and treatment of lipohyperplasia dolorosa (lipoedema) and, as part of his team with well over 12,000 operations, Professor Cornely is highly skilled in the field of resective operative lymphology.

 

Currently, Professor Cornely and his medical centres are leading the LIPLEG study, approved by the Federal Joint Committee of Doctors and Health Insurance in Germany (G-BA: Gemeinsamen Bundesausschuss). Professor Cornely lectures at many national and international conferences and congresses and promotes the interdisciplinary exchange of information between renowned specialists and scientists on all aspects of lymphology, to be able to pursue scientific questions in a bundled and competent manner and to work them up in a goal-oriented manner.

Dr Joanna Dudek

Assistant Professor, SWPS University in Warsaw, Poland

Speaker's biography

Joanna Dudek is a psychologist, psychotherapist, and Assistant Professor at SWPS University in Warsaw, Poland. Her academic work focuses on the quality of life and psychological functioning of individuals living with lipoedema. She has conducted pioneering research highlighting the importance of psychosocial functioning and overall wellbeing in this patient group.

 

She is the co-author of numerous scientific articles, book chapters, and conference presentations, and has delivered workshops on the psychological aspects of living with lipoedema internationally. She is also actively involved in research on psychological interventions aimed at improving patients’ functioning and quality of life.

 

Her current international research includes studies on lipoedema and pregnancy, addressing specific challenges in this area.

 

Dr Dudek is a member of the Parliamentary Team on Lipoedema in Poland, where she contributes to efforts aimed at increasing public awareness, improving patient care, and reducing stigma and misunderstanding surrounding the condition.

 

Her overarching goal is to advance knowledge about lipoedema and promote an integrated approach to care that brings together both medical and psychosocial perspectives.

Lorraine Nisbet

Lorraine Nisbet

Clinical and Education Manager, Daylong Direct

Speaker's biography

Holding a BSc (Hons) in Microbiology and Immunology, Lorraine has a career spanning over 20 years in wound care and medical devices.

 

Following graduation, Lorraine joined Johnson & Johnson Wound Management, remaining with the business through its evolution into Systagenix and subsequently Acelity/KCI. During this time, Lorraine held roles across R&D, clinical affairs, and scientific affairs, providing technical and scientific support across the moist wound healing, biologics, diagnostics, and antimicrobial platforms. During this time, Lorraine also went on secondment to the University of Massachusetts Plastic Surgery Department, where she undertook research projects bridging laboratory science and clinical practice in wound healing biology. Lorraine subsequently broadened their medical device experience as Clinical Strategy Manager at RB Healthcare, with responsibility across foot care, eye care, and the sexual health portfolio, before returning to Acelity as Scientific Affairs Manager for Advanced Wound Dressings. In this role, Lorraine led scientific, educational, and clinical projects, working closely with the medical education team — a collaboration that led to a transition into a Medical Education Manager role in 3M.

 

Lorraine currently serves as Clinical and Education Manager at Daylong Direct, a distributor and manufacturer of compression garments for lipoedema and lymphoedema. In this role, she is responsible for delivering training and education to healthcare professionals, and for supporting the clinical evaluation and evidence generation for their product portfolio.

Isabel Forner-Cordero

Associate Professor Isabel Forner-Cordero

Doctor, University Hospital La Fe, University of Valencia, Spain

Speaker's biography

After being qualified as in 1998, Associate Professor Forner-Cordero was trained in lymphology in France, Germany and Belgium. She has been working in the Lymphedema Unit in University Hospital La Fe, Valencia (Spain), since July 2000, in the diagnosis and treatment pf lymphedema and lipoedema. She has conducted some research and published the results in international journals and congresses.

 

Associate Professor Forner-Cordero is a Member of the Executive Committee of the European Society of Lymphology, Member of the Board of the Lipedema World Alliance, member of the Board of the International Compression Club, Developing partner of VASCERN and President and Founder of the Spanish Group of Lymphology. She is also Associate professor at University of Valencia.

 

ORCID identification: https://orcid.org/0000-0003-2778-037X

Anne Williams

Dr Anne Williams

Lymphology Consultant Nurse, Lipoedema UK

Speaker's biography

Anne is an experienced nurse consultant, with a specialist focus on supporting people living with lymphoedema and lipoedema. Anne worked within the NHS for over 25 years before establishing Esklymphology, a clinical and consultancy organisation, in 2004. Anne is a retired university lecturer and now supports Lipoedema UK as a Research Advisor. Anne has led and collaborated on a range of research studies relating to lymphoedema and lipoedema. She took a leadership role in the development of the Best Practice Guidelines for the Management of Lipoedema in the UK in 2017.

 

Anne provides clinical treatment, care and support to people with lymphoedema, and women with lipoedema. She has worked with several third sector organisations, supporting them to develop and deliver services. She currently volunteers with Lipoedema UK where she supports academic developments, advocating to improve the opportunities for women with lipoedema in the UK and beyond.

Dr Philipp Kruppa

Consultant Plastic & Reconstructive Surgeon, Department of Plastic, Reconstructive and Aesthetic Surgery – Hand Surgery and Burn Center, University Hospital Schleswig-Holstein, Campus Lübeck, Germany

Speaker's biography

Dr Philipp Kruppa is a plastic and reconstructive surgeon specialising in lymphatic diseases and microsurgery, with a primary clinical and research focus on lipoedema. His work centers on improving the diagnosis, evaluation, and surgical management of this often underrecognised condition. Lipoedema reduction surgery, combined with systematic assessment of symptoms and lymphatic function, is a cornerstone of his clinical practice. His research is dedicated primarily to lipoedema. Beginning during residency, his work has explored disease pathophysiology, staging, comorbidities, imaging, and patient-reported outcomes following surgery.

 

Dr Kruppa has authored numerous scientific publications, including studies demonstrating significant symptom relief and quality-of-life improvements after surgical treatment. As principal investigator, he led a mechanistic tissue study linking adipocyte hypertrophy, tissue remodeling, and macrophage polarisation to disease severity. Dr Kruppa’s ongoing research aims to identify objective biomarkers for lipoedema through molecular tissue and blood analysis, alongside advanced imaging techniques, with the goal of enabling more reliable diagnosis.

 

Actively engaged in international collaborations, Dr Kruppa works to advance standardised care and multicenter research. His overarching goal is to reduce the burden of lipoedema through improved diagnostics, optimised treatments and deeper understanding of disease mechanisms.

Linda-Anne Kahn

Linda-Anne Kahn CLT-LANA, NCBTMB

Lymphedema Therapist, Lymphatic Therapy Services, San Diego, USA

Speaker's biography

Linda-Anne Kahn, NCBTMB, CLT-LANA is a Lymphedema Therapist, Clinical Aromatherapist and Board-Certified Massage Therapist with over 35 years of clinical experience.

 

She holds International certifications from the Dr. Vodder School, Austria; Foeldi School, Germany; and University of Adelaide, Drs. John and Judith Casley-Smith, Australia. She is nationally certified by the Lymphology Association of North America and is a sought-after speaker at Lymphatic and Aromatherapy conferences, nationally and internationally. She is nationally certified by the Lymphology Association of North America (LANA).

 

Linda Anne is the founder and director of Lymphatic Therapy Services in San Diego, California, USA. She is a co-author of the Standard of Care for Lipedema USA and “Lymphedema and Lipedema Nutrition Guide” and is founding member of the Lipedema World Alliance.

Jonathan Kartt

Jonathan Kartt

Chief Executive Officer, Lipedema Foundation, US

Speaker's biography

Jonathan Kartt is CEO of the Lipedema Foundation, a US-based charity dedicated to advancing the scientific understanding of Lipedema and laying the groundwork for the next generation of diagnostics and treatments. The Foundation supports investigator-initiated research worldwide, funds infrastructure including the Lipedema Foundation Registry and tissue biobanking efforts, and convenes patients, clinicians, and scientists to accelerate progress in the field. He joined the Foundation in 2021 from the Rita Allen Foundation, where he led programs in basic biomedical research and chronic pain. Earlier, he spent eight years as a strategy consultant at Strategic Decisions Group and The Bridgespan Group, advising life sciences companies, nonprofits and foundations. He is committed to building the evidence base and resources that lipedema patients and their care teams urgently need.

Sara Percival-Mills

Sara Percival-Mills

Clinical Advisor and Trustee, Lipoedema UK

Speaker's biography

Sara Percival-Mills MSc has been a Clinical Advisor for Lipoedema UK for over 10 years and became a Trustee in 2022. With a clinical background, an MSc in Advance Practice and qualifications in lymphoedema management, she is the Lead for the North Essex Lymphoedema Service which she helped set up in 2008 with charitable funding. Since this time, she has worked with Commissioning Boards and successfully secured NHS funding in 2015 and again in 2018 to extend the service remit to be able to see Lipoedema patients as well. She is passionate about raising awareness of Lipoedema and the impact it can have while promoting care equality. Outside of work, Sara enjoys the challenges of gardening, watching rugby and has recently taken up golf.

Agenda

View the programme

Welcome and introduction

Professor Julia Manning, Dean of Education, Royal Society of Medicine

Session 1: Diagnosis

Chair: Sharie Fetzer, Chair of Lipoedema UK

What is lipoedema and the importance of an early diagnosis

Dr Anne Williams, Lymphoedema Nurse Consultant & Research Advisor Lipoedema UK, Esklymphology

Establishing global consensus: A Delphi study on the definition and management of lipoedema

Dr Philipp Kruppa, Consultant Plastic, Reconstructive & Aesthetic Surgeon, University Hospital Schleswig-Holstein, Germany

Lipoedema: Psychological mechanisms and the impact on quality of life

Dr Joanna Dudek, Assistant Professor, University Warsaw, Poland

Real voices: Living with lipoedema – A familial story

Sandra Slaughter, Coach, and Integrative Therapist, Personal Coaching and Training Services

Insights from a patient and clinical survey on the challenges and needs of patients with lipoedema

Lorraine Nisbet, Clinical Manager, Daylong Direct

Panel discussion

Session 2: Management

Chair: Kris Jones, Managing Director and Clinical Nurse Specialist, Trustee, Lipoedema UK

Integrating self-management and multidisciplinary care

Sara Percival-Mills, Trustee and Clinical Consultant, Lipoedema UK

A holistic approach to managing lipoedema and the role of nutrition

Linda Ann Kahn, Director of Lymphatic Services of San Diego Lymphatic Therapy Services, San Diego, California, United States

Compression in lipoedema management

Isabel Forner-Cordero, Associate Professor, Hospital University of Valencia, Spain

Real voices: Experiences of self-managing lipoedema
Panel discussion
Comfort break

Session 3: Research

Chair: Kate Forster, Trustee, Lipoedema UK and General Secretary of Lipoedema World Alliance

Real voices: Living with lipoedema
Lipoedema: Comorbidities and surgical approaches

Professor Manuel Cornely, Scientific Director, LY.SEARCH Germany

An update on The NICE review: HealthTec guidance (HTG618) for liposuction for chronic lipoedema

Dr Anne Williams

Lipoedema: Current evidence and what we know so far

Associate Professor Ramin Shayan, Consultant Plastic Surgeon, St Vincent Institute for Medical Research, Australia

Advancing lipoedema science: The role of the Lipoedema Foundation

Jonathan Kartt, Chief Executive Officer, Lipedema Foundation, US

Panel discussion
Closing remarks
Close of meeting

Location

Online

Registration for this webinar will close 1 hour before the scheduled start time. Registered delegates will receive the webinar access link approximately 1 hour before the event. Late registrations will not be accepted. 

Where the webinar is recorded, recordings will be available to registered delegates for up to 60 days following the live event, subject to speaker permission. Access details will be shared within 24 hours of the webinar. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in the future via RSM digital channels.